Consumer & Retail · Wholesale Distributors
Muller & Phipps (Ceylon) PLC is a Sri Lanka-based importer and distributor operating in the healthcare and pharmaceutical sector.
MULL shares are up 65.2% over the past year and last closed at Rs 3.80 on Nov 17, 2026.
Fundamentals
| Line | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | Rs 587.3M -19.0% | Rs 724.6M -5.1% | Rs 763.5M +44.9% | Rs 526.9M -50.5% | Rs 1.1B +41.8% | Rs 750.9M -11.4% | Rs 847.1M -14.3% | Rs 988.6M +5.5% |
| Operating profit | Rs -49.2M | Rs -56.8M | Rs 87.0M +11.4% | Rs 78.1M -34.1% | Rs 118.5M +63.2% | Rs 72.7M | Rs -25.3M | Rs -2.2M |
| Net profit | Rs -71.4M loss narrowed | Rs -83.7M fell into loss | Rs 75.1M turned profitable | Rs -88.3M loss widened | Rs -36.7M fell into loss | Rs 66.8M turned profitable | Rs -104.0M loss widened | Rs -60.5M fell into loss |
| EPS | -0.25 | -0.30 | 0.27 | -0.31 | -0.13 | 0.24 | -0.37 | -0.21 |
Compared with the same period a year earlier.
Per-share figures are as reported, not adjusted for splits.
Dividend history
Dividend dates and yearly totals →| Ex-date | Dividend | Per share | Payment date |
|---|---|---|---|
| - | 2018 | Rs 0.05 | Mar 28, 2018 |
| - | 2017 | Rs 0.07 | Mar 29, 2017 |
| - | 2014 | Rs 0.05 | - |
Upcoming dividends, rights issues and splits across the CSE: dividend calendar →
| # | Company | Mkt cap | P/E | P/B | EPS | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| 1 | CTC.N0000 | Rs 342.8B | 11.4 | 32.05 | 161.07 | 282.11% | 8.61% |
| 2 | DIST.N0000 | Rs 267.7B | 15.7 | 12.29 | 3.71 | 90.67% | 5.15% |
| 3 | CARG.N0000 | Rs 175.0B | 15.7 | 4.02 | 43.27 | 25.61% | 2.91% |
| 4 | LION.N0000 | Rs 154.2B | 13.8 | 3.32 | 139.93 | 26.25% | 4.16% |
| 5 | CCS.N0000 | Rs 118.8B | 15.4 | 5.19 | 8.12 | 33.72% | 5.53% |
| 6 | SINS.N0000 | Rs 89.0B | 11.2 | 3.96 | 6.78 | 35.26% | 2.62% |
| 7 | BREW.N0000 | Rs 52.5B | 8.8 | 2.05 | 283.73 | 23.32% | 3.73% |
| 8 | LAMB.N0000 | Rs 38.1B | 47.6 | 7.93 | 25.46 | 16.67% | 0.00% |
| 33 | MULL.N0000 · this company | Rs 1.1B | - | - | -0.24 | - | 0.00% |
| Sector median · 35 companies | - | 14.4 | 1.73 | - | - | 1.73% |
About Muller & Phipps (Ceylon) PLC
Muller & Phipps (Ceylon) PLC is a Sri Lanka-based importer and distributor operating in the healthcare and pharmaceutical sector. The Group distributes pharmaceutical and healthcare products through an ERP-enabled, island-wide network supported by 16 distributors and more than 3,000 customer touchpoints. The Company’s activities include pharmaceutical distribution, marketing and medical engagement, and supply chain management, underpinned by compliance-driven operations and digital sales platforms. During the year the Group expanded into therapeutic nutrition with the introduction of Dreavia Switzerland nutrition products, including Dreavia Rontamil. The Group operates in Sri Lanka and comprises Muller & Phipps (Ceylon) PLC and its wholly owned subsidiary, Muller & Phipps (Health Care) Limited, leveraging distribution, professional engagement, and digital channels to service healthcare professionals, retailers and other customers nationwide.
AI analysis
bearishEvidence points bearish: September still produced a LKR 3 million net loss while equity attributable to owners was negative. The counterpoint is that the business returned to an operating profit.
Read the full report (Nov 9, 2026) →News sentiment
Describes news flow, not a forecastNo scored news in the last 30 days.
Consumer & Retail sector: what is happening
Last 14 days to Nov 18, 2026Consumer staples news centred on Budget proposals to exempt printed and exercise books from VAT, remove PAL on newsprint imports and cut CESS rates on selected import lines, reducing costs for print retail. Household spending rose largely with market prices, indicating pressure on real consumption. The IMF highlighted lower excise on imported liquor than domestic alcohol, keeping tax neutrality and border controls in focus for the beverages market.
The stories behind it
Auto-generated from 7 sector news articles over 14 days. Not investment advice.